SI1478355T1 - Protitumorni sestavki, ki vsebujejo taksanske derivate - Google Patents
Protitumorni sestavki, ki vsebujejo taksanske derivateInfo
- Publication number
- SI1478355T1 SI1478355T1 SI200230525T SI200230525T SI1478355T1 SI 1478355 T1 SI1478355 T1 SI 1478355T1 SI 200230525 T SI200230525 T SI 200230525T SI 200230525 T SI200230525 T SI 200230525T SI 1478355 T1 SI1478355 T1 SI 1478355T1
- Authority
- SI
- Slovenia
- Prior art keywords
- compositions containing
- taxane derivatives
- containing taxane
- antitumor compositions
- antitumor
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 1
- 231100000632 Spindle poison Toxicity 0.000 abstract 1
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000340 anti-metabolite Effects 0.000 abstract 1
- 229940100197 antimetabolite Drugs 0.000 abstract 1
- 239000002256 antimetabolite Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000008512 biological response Effects 0.000 abstract 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000003607 modifier Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 1
- -1 platinum coordination complex Chemical class 0.000 abstract 1
- 229940063683 taxotere Drugs 0.000 abstract 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 abstract 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/813,018 US6441026B1 (en) | 1993-11-08 | 2001-03-21 | Antitumor compositions containing taxane derivatives |
| EP02713093A EP1478355B1 (en) | 2001-03-21 | 2002-03-21 | Antitumor compositions containing taxane derivatives |
| PCT/IB2002/000853 WO2002074289A2 (en) | 2001-03-21 | 2002-03-21 | Antitumor compositions containing taxane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1478355T1 true SI1478355T1 (sl) | 2007-08-31 |
Family
ID=25211230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200230525T SI1478355T1 (sl) | 2001-03-21 | 2002-03-21 | Protitumorni sestavki, ki vsebujejo taksanske derivate |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6441026B1 (https=) |
| EP (1) | EP1478355B1 (https=) |
| JP (1) | JP4467885B2 (https=) |
| CN (2) | CN101590057A (https=) |
| AT (1) | ATE355837T1 (https=) |
| AU (1) | AU2002244877B2 (https=) |
| BR (1) | BR0208274A (https=) |
| CA (1) | CA2440160C (https=) |
| CY (1) | CY1106582T1 (https=) |
| DE (1) | DE60218751T2 (https=) |
| DK (1) | DK1478355T3 (https=) |
| EA (1) | EA006878B1 (https=) |
| ES (1) | ES2282400T3 (https=) |
| HU (1) | HUP0500478A2 (https=) |
| IL (1) | IL157992A (https=) |
| MX (1) | MXPA03008539A (https=) |
| PT (1) | PT1478355E (https=) |
| SI (1) | SI1478355T1 (https=) |
| WO (2) | WO2002074232A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| FR2698871B1 (fr) | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| WO2002072085A1 (en) * | 2001-03-14 | 2002-09-19 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| ITRM20020191A1 (it) * | 2002-04-08 | 2003-10-08 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att |
| HRPK20041072B3 (hr) * | 2002-05-17 | 2007-07-31 | Aventis Pharma S.A. | Primjena docetaxela/doxorubicina/ciklofosfamida uadjuvantnoj terapiji karcinoma dojke i jajnika |
| WO2004035034A2 (en) * | 2002-10-16 | 2004-04-29 | Ilex Products, Inc. | Clofarabine and taxane chemotherapy combination |
| ITMI20030317A1 (it) * | 2003-02-21 | 2004-08-22 | Pharmacia Italia Spa | Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale. |
| WO2004103344A1 (en) * | 2003-05-20 | 2004-12-02 | Aronex Pharmaceuticals, Inc. | Combination chemotherapy comprising a liposomal platinum complex |
| CN100340296C (zh) * | 2005-02-03 | 2007-10-03 | 山东蓝金生物工程有限公司 | 一种抗癌体内植入剂 |
| US8735394B2 (en) * | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| SI1853250T1 (sl) | 2005-02-18 | 2012-01-31 | Abraxis Bioscience Llc | Kombinacije in reĹľimi dajanja terapevtskih sredstev in kombinirana terapija |
| ATE465205T1 (de) * | 2005-12-05 | 2010-05-15 | Nitto Denko Corp | Polyglutamat-aminosäure-konjugate und verfahren |
| EP1913958B1 (en) * | 2006-08-03 | 2009-12-23 | Sanofi-Aventis | Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab |
| US20080181852A1 (en) * | 2007-01-29 | 2008-07-31 | Nitto Denko Corporation | Multi-functional Drug Carriers |
| JP2010526159A (ja) * | 2007-04-10 | 2010-07-29 | 日東電工株式会社 | 多機能性ポリグルタミン酸塩薬物担体 |
| PT2155255E (pt) | 2007-05-09 | 2013-10-15 | Nitto Denko Corp | Composições que incluem um composto hidrofóbico e um conjugado de poliaminoácido |
| CN101730549B (zh) * | 2007-05-09 | 2015-12-09 | 日东电工株式会社 | 与铂类药物结合的聚合物 |
| US20080279778A1 (en) * | 2007-05-09 | 2008-11-13 | Nitto Denko Corporation | Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs |
| WO2009111271A1 (en) * | 2008-03-06 | 2009-09-11 | Nitto Denko Corporation | Polymer paclitaxel conjugates and methods for treating cancer |
| KR20130028727A (ko) | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| NZ717490A (en) | 2010-03-29 | 2017-12-22 | Abraxis Bioscience Llc | Methods of treating cancer |
| BR112012030909A2 (pt) | 2010-06-04 | 2020-08-18 | Abraxis Bioscience, Llc | métodos de tratamento de câncer pancreático |
| KR20130140033A (ko) * | 2010-11-12 | 2013-12-23 | 엔도사이트, 인코포레이티드 | 암을 치료하는 방법들 |
| CN102241648B (zh) * | 2011-01-31 | 2016-08-03 | 沈阳东星医药科技有限公司 | 抗多药耐药紫杉烷类衍生物及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601676B1 (fr) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Procede de preparation du taxol et du desacetyl-10 taxol |
| FR2601675B1 (fr) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US4876399A (en) | 1987-11-02 | 1989-10-24 | Research Corporation Technologies, Inc. | Taxols, their preparation and intermediates thereof |
| US5136060A (en) | 1989-11-14 | 1992-08-04 | Florida State University | Method for preparation of taxol using an oxazinone |
| US5015744A (en) | 1989-11-14 | 1991-05-14 | Florida State University | Method for preparation of taxol using an oxazinone |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| WO1992019765A1 (en) | 1991-05-08 | 1992-11-12 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer |
| US5645988A (en) | 1991-05-08 | 1997-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of identifying drugs with selective effects against cancer cells |
| US5284865A (en) | 1991-09-23 | 1994-02-08 | Holton Robert A | Cyclohexyl substituted taxanes and pharmaceutical compositions containing them |
| US5229526A (en) | 1991-09-23 | 1993-07-20 | Florida State University | Metal alkoxides |
| US5262409A (en) | 1991-10-11 | 1993-11-16 | Fred Hutchinson Cancer Research Center | Binary tumor therapy |
| US5294737A (en) | 1992-02-27 | 1994-03-15 | The Research Foundation State University Of New York | Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom |
| FR2697752B1 (fr) | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| EP0982028A1 (en) * | 1998-08-20 | 2000-03-01 | Aventis Pharma S.A. | New use of taxoid derivatives |
-
2001
- 2001-03-21 US US09/813,018 patent/US6441026B1/en not_active Expired - Fee Related
-
2002
- 2002-03-21 EP EP02713093A patent/EP1478355B1/en not_active Expired - Lifetime
- 2002-03-21 CN CNA2009101299448A patent/CN101590057A/zh active Pending
- 2002-03-21 BR BR0208274-8A patent/BR0208274A/pt not_active IP Right Cessation
- 2002-03-21 CA CA2440160A patent/CA2440160C/en not_active Expired - Lifetime
- 2002-03-21 CN CNA028068572A patent/CN1536995A/zh active Pending
- 2002-03-21 DE DE60218751T patent/DE60218751T2/de not_active Expired - Lifetime
- 2002-03-21 AT AT02713093T patent/ATE355837T1/de active
- 2002-03-21 JP JP2002572997A patent/JP4467885B2/ja not_active Expired - Lifetime
- 2002-03-21 WO PCT/IB2002/002239 patent/WO2002074232A2/en not_active Ceased
- 2002-03-21 MX MXPA03008539A patent/MXPA03008539A/es active IP Right Grant
- 2002-03-21 ES ES02713093T patent/ES2282400T3/es not_active Expired - Lifetime
- 2002-03-21 EA EA200301047A patent/EA006878B1/ru not_active IP Right Cessation
- 2002-03-21 PT PT02713093T patent/PT1478355E/pt unknown
- 2002-03-21 DK DK02713093T patent/DK1478355T3/da active
- 2002-03-21 SI SI200230525T patent/SI1478355T1/sl unknown
- 2002-03-21 AU AU2002244877A patent/AU2002244877B2/en not_active Ceased
- 2002-03-21 WO PCT/IB2002/000853 patent/WO2002074289A2/en not_active Ceased
- 2002-03-21 HU HU0500478A patent/HUP0500478A2/hu unknown
-
2003
- 2003-09-18 IL IL157992A patent/IL157992A/en not_active IP Right Cessation
-
2007
- 2007-05-10 CY CY20071100643T patent/CY1106582T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2282400T3 (es) | 2007-10-16 |
| IL157992A (en) | 2008-08-07 |
| JP2004536790A (ja) | 2004-12-09 |
| CN101590057A (zh) | 2009-12-02 |
| EP1478355B1 (en) | 2007-03-07 |
| US20020031505A1 (en) | 2002-03-14 |
| US6441026B1 (en) | 2002-08-27 |
| EA200301047A1 (ru) | 2004-06-24 |
| CA2440160A1 (en) | 2002-09-26 |
| CY1106582T1 (el) | 2012-01-25 |
| MXPA03008539A (es) | 2004-08-11 |
| DE60218751D1 (de) | 2007-04-19 |
| CN1536995A (zh) | 2004-10-13 |
| CA2440160C (en) | 2011-07-05 |
| AU2002244877B2 (en) | 2006-07-20 |
| DK1478355T3 (da) | 2007-07-02 |
| EA006878B1 (ru) | 2006-04-28 |
| DE60218751T2 (de) | 2007-11-22 |
| HUP0500478A2 (hu) | 2005-08-29 |
| WO2002074289A3 (en) | 2004-09-02 |
| WO2002074232A2 (en) | 2002-09-26 |
| JP4467885B2 (ja) | 2010-05-26 |
| ATE355837T1 (de) | 2007-03-15 |
| EP1478355A2 (en) | 2004-11-24 |
| WO2002074289A2 (en) | 2002-09-26 |
| BR0208274A (pt) | 2004-07-13 |
| PT1478355E (pt) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1478355T1 (sl) | Protitumorni sestavki, ki vsebujejo taksanske derivate | |
| PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
| BR0012046A (pt) | Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória | |
| AU2002327180A1 (en) | Detection and therapy of vulnerable plaque with photodynamic compounds | |
| MXPA02012271A (es) | Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor. | |
| IL140093A0 (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same | |
| RU94029662A (ru) | Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения | |
| BR0208741A (pt) | Derivados de piperidina | |
| BRPI0415779A (pt) | tratamento de doenças proliferativas usando um oligÈmero antisenso iap e um agente quimioterápico | |
| ECSP045378A (es) | Derivados novedosos de diazabiciclononeno | |
| CA2218663A1 (en) | Benzisoxazole and indazole derivatives as antipsychotic agents | |
| GB9714274D0 (en) | Pharmaceutical composition | |
| ATE268175T1 (de) | Decursin-enthaltende pharmazeutische zusammensetzungen | |
| EP1511472A4 (en) | USEFUL COMPOUNDS FOR THE TREATMENT OF ANTHRAX AND INHIBITION OF THE LETAL FACTOR | |
| AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
| WO2004056832A3 (en) | Epothilone derivatives | |
| AU2002214197A1 (en) | Macrolides | |
| SE9904128D0 (sv) | Novel compounds | |
| YU69503A (sh) | Kombinacija taksana i ciklin-zavisne kinaze | |
| IL173809A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| IL173895A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| PL350331A1 (en) | C10 carbamoyloxy substituted taxanes as antitumor agents | |
| WO2008015578A3 (en) | Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab | |
| EE200200688A (et) | Akrüloüüldistamütsiini derivaati, mikrotuubulivastast toimeainet ja/või antimetaboliiti sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritud ravimpreparaat | |
| CA2420056A1 (en) | 1-amino-alkylcyclohexanes as trypanocidal agents |